Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (NasdaqGS:MRNA) from Buy to ...

Japan's SoftBank is in talks to invest as much as $25 billion into ChatGPT maker OpenAI, the Financial Times reported on ...

The Federal Reserve's future moves on interest rates in 2025 will be in a narrow range unless the trajectory of inflation ...

Nvidia stock trades lower, ASML rises after fourth-quarter bookings top analysts’ forecasts, and Wall Street awaits quarterly ...

Microsoft (NASDAQ:MSFT) has lagged behind the NASDAQ over the past year but is off to a strong start in 2025, outperforming ...

The U.S. economy slowed but continued to grow at a healthy rate in the fourth quarter, if forecasters are correct.

In a report shared with MarketWatch on Wednesday, the Goldman team, led by chief global equity strategist Peter Oppenheimer, said that while the buzz surrounding China's DeepSeek has raised questions ...

Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the ...

Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months. Moderna shares (MRNA) fell 2% in ...

The Bank of England is likely to cut interest rates far further and faster than markets are currently expecting, according to ...

The Federal Reserve and the European Central Bank will announce their interest rate decisions today and tomorrow respectively ...